
Virgo Investment Group
555 Twin Dolphin Dr Ste 615, Redwood City, California, 94065, United States
Overview
Virgo Investment Group ("Virgo") is an opportunistic, private investment firm with a value investment philosophy, a bias toward the preservation of capital and an emphasis on generating a current yield on invested capital. Virgo leverages macroeconomic viewpoints to identify market seams where there are mis-pricings and where investment returns are less correlated with market credit spreads and corporate valuation multiples. Virgo's strategy combines investments in both special situations and credit opportunities to optimize risk-adjusted returns. This strategy is enabled by a flexible mandate to invest across the capital structure in industries such as healthcare; financial services; software, media & information services; aviation and energy.
- Total investments
- 13
- Lead investments
- 12
- Investments · 12mo
- 0
- Active investors
- 8
Sector focus
- Finance
- Financial Exchanges
- Financial Services
- Venture Capital
Investment portfolio
- Swift Medical
Led · Equity · Jan 2024
Swift Medical builds AI-driven digital wound care tools and an imaging app used to standardize assessment, documentation, and remote care across the continuum of care. Core product offerings highlighted in the announcement include SmartTissue™, AutoDepth™ and HealingIndex™, which aim to improve wound evaluations, reduce treatment variability and identify risk more accurately. The company reports being the trusted wound care technology partner of more than 4,000 healthcare facilities in North America with over 20,000 clinical users. Its platform has captured more than 20 million wound images and 40 million assessments, which underpin its clinical analytics and remote-care capabilities. Swift says its technology is associated with 37% faster wound healing and a 39% increase in measurement accuracy on darker skin tones in cited studies. Headquartered in Toronto, Swift operates across the U.S. and Canada and is pursuing broader commercialization and deployment of its AI tools. Swift Medical provides an AI-driven digital wound care platform that offers high-precision imaging, compliant documentation, clinical analytics, and remote care. The company serves more than 4,000 healthcare facilities across North America and has over 20,000 clinical users. Its platform has captured more than 20 million wound images and 40 million assessments, supporting standardized and equitable wound care. Headquartered in Toronto, Swift is expanding operations across the U.S. and Canada. The company plans significant platform enhancements in 2024, including enhanced data security, improved interoperability, and enhanced device capabilities. The recent financing is intended to accelerate those technology improvements and expand the company’s reach. Swift Medical offers an AI-powered digital wound care platform that lets patients and clinicians capture high-precision wound images with a mobile phone, autonomously determine wound dimensions and clinical characteristics, enable virtual wound consultations, and provide real-time predictive insights. The technology is used by over 4,000 healthcare organizations across all 50 states and spans the full continuum of care. The company says it has grown 300% year-over-year in every new market it has entered over the past three years. Swift Medical positions itself as the dominant market player in digital wound management and emphasizes improving prevention, treatment, and management of wounds. With the new funding, the company plans to expand its market position and scale its platform across the care continuum in North America and continue growing its team. The stated mission is to prevent wounds before they occur and improve quality of care for every patient with a wound. Swift Medical offers an enterprise-grade, smartphone-ready Swift Skin and Wound software that delivers advanced wound visualization and touchless 3D measurement without touching the wound or requiring extra equipment. The platform captures images and measurements including wound depth, provides automatic risk scoring, schedules assessments, and supports claims submission to streamline clinical and administrative wound care workflows. Swift has been adopted by over 1,000 healthcare facilities managing more than 100,000 beds and reports helping heal over 10,000 patients a month. The company has partnerships with PointClickCare and Healogics and positions itself as a global market leader and enterprise solutions partner in digital wound care management. Management says the Series A funding will be used to expand reach and bring Swift’s solution to every bedside in hospitals and care facilities. Swift frames its mission around digitizing wound care management to augment clinician capabilities and address the global burden of chronic wounds.
- Lifespark
Led · Series B · Oct 2021
Lifespark is a Minneapolis-based leader in whole-person services for seniors, investing in technology to connect, predict, and track seniors' medical and well-being outcomes. Its core product is the Lifespark Operating System, a proprietary technology platform that integrates first-, second-, and third-party data and uses predictive analytics and machine learning to generate recommendations. The company describes its technology as holistic at its core and focused on improving people’s experience through connected insights. Lifespark intends to use the funds to continue advancing its operating system and proprietary platform and to work with UCare, a Minnesota Medicare Advantage provider, to serve Minnesota seniors holistically with a multiproduct strategy. The company raised $20 million in a Series B to support these efforts. Joel Theisen, BSN, is CEO and founder; the company was formerly known as Lifesprk. Lifesprk operates a proprietary, technology-enabled Life Experience Alternative Delivery System (LEADS) that combines whole-person primary care, in-home health, engagement, navigation and SDoH services for seniors. Its technology stack includes an Electronic Life Record (ELR), EMR integration, SDoH and first- and third-party data to enable predictive analytics and interoperability. The company positions LEADS as a payor-agnostic, value-based population health solution designed to improve client experience, outcomes, and lower total cost of care. Lifesprk plans to invest in technological innovations to operationalize LEADS and address tracking of SDoH and interoperability gaps. The firm says it has a proven track record of consistent growth with solid financials and outcomes and experience scaling and integrating with partners. Lifesprk was founded in 2004 and is based in St. Louis Park, Minnesota.
- Now
Led · Series A · Jun 2021
Now is a Georgia-based fintech founded in 2010 by Stacey Abrams and Lara O’Connor Hodgson that accelerates invoice payments for small businesses. Through its NowAccount product the company pays 100% of submitted invoices immediately minus a 3% merchant fee. Now raises low-cost capital by selling bonds in the capital markets, a model its cofounder likens to American Express, and has built systems to manage the cost and risk while awaiting payment 30+ days later. To date the company has served over 1,000 small businesses and processed over $700 million in transactions. The pandemic has lengthened average invoice payment times from about 50 days to between 70–80 days, increasing demand for its offering. The $9.5M Series A led by Virgo Investment Group will be used to scale Now’s offerings and to fund marketing and advertising to expand its customer base.
- Apricus Health
Led · Equity · Jan 2021
Apricus Health operates a Health Network of primary care and specialty providers with more than 590 practitioners, 63 provider groups and 220 locations across Maricopa, Pinal, Coconino and Yavapai counties in Arizona. Its services include in‑office visits, telehealth, personal care navigators, remote patient monitoring and free home delivery of medications, with 24/7 patient access. The company emphasizes Senior Health Management, enrolling patients with chronic conditions in proactive chronic care management programs and supplying remote monitoring devices. Apricus reports that these programs have led to improved outcomes, lower hospitalizations and reduced healthcare spending. The Centers for Medicare and Medicaid Services awarded Apricus approval to operate a Direct Contracting Entity (DCE); implementation was underway with full operations starting April 1, 2021. The company plans to extend participation in DCE programs to other states in 2022.
- Realife Tech
Led · Series A · Jun 2020
Founded in 2014 as LiveStyled, Realife Tech provides a unified platform that joins data from mobile apps, ticketing, Wi‑Fi, POS, digital screens and other systems to create a single view of attendees. The company offers venue-facing tools such as entry-slot allocation, contactless collection, targeted messaging and checklists to help venues implement social‑distancing measures. It recently rebranded and relaunched with a Covid Safety Hub intended to assist venues in safely reopening. Realife Tech integrates footfall analytics from Crowd Connected’s Colocator to track movement and inform operational decisions. The platform is used by notable clients including LA Galaxy, Indianapolis Motor Speedway and London’s The O2. The company announced $7.2 million in fresh funding alongside the relaunch.